This inventor holds 34 USPTO granted patents and 30 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Bioagent Detection. Top assignees: Ibis Biosciences, Inc., Isis Pharmaceuticals, Inc., Other. Active years: 1998-2020.
Location History:
- Beaverton, OR (US) (1998)
- Oceanside, CA (US) (2007 - 2020)
Company Filing History:
31 out of 113 
2 out of 1,035 
1 out of 834,307 Years Active: 1998-2020
Areas of Expertise:
Title: Thomas A. Hall: Innovator in Bioagent Detection Technologies
Introduction
Thomas A. Hall, an esteemed inventor based in Oceanside, CA, holds an impressive portfolio of 33 patents. His innovative work primarily focuses on the field of bioagent detection, particularly in identifying bacterial DNA amidst contaminating non-bacterial DNA. Throughout his career, Hall has contributed significantly to advancements in the detection of bioagents, aiding in various scientific and medical applications.
Latest Patents
Among his latest patents is the ground-breaking invention of bioagent detection oligonucleotides. This invention encompasses compositions, methods, and systems designed to identify, detect, and quantify bacterial DNA even in the presence of overwhelming amounts of contaminating human DNA. The sophisticated oligonucleotides developed by Hall are configured to accurately detect small amounts of bacterial DNA, a crucial leap in bioagent detection technology.
Career Highlights
Throughout his career, Hall has been associated with leading companies in the biotechnology sector, notably Ibis Biosciences, Inc. and Isis Pharmaceuticals, Inc. His work at these organizations has resulted in significant advancements in the field and has established him as a key figure in biotechnology innovation. His experience in these companies has provided him with a solid foundation for his inventions and patents.
Collaborations
Throughout his journey as an inventor, Thomas A. Hall has collaborated with notable professionals in the industry. Colleagues such as Rangarajan Sampath and David J. Ecker have partnered with him on various projects, contributing their expertise to the development of groundbreaking technologies in bioagent detection. Such collaborations highlight the importance of teamwork in advancing innovations within the scientific community.
Conclusion
Thomas A. Hall's contributions to the field of bioagent detection and his impressive portfolio of patents underscore his role as a leading innovator in biotechnology. His dedication to developing methods that enhance the identification and quantification of bacterial DNA is vital for advancing scientific research and improving diagnostic technologies. As he continues to innovate, his work will undoubtedly have a lasting impact on the field.